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Gene expression technologies allow the analysis of gene networks whose expression is associated
with speciﬁc pathological conditions compared with normal tissue. We hypothesized that histo-
logically normal tissue obtained in different ways (percutaneous or surgical liver biopsies), usu-
ally used as normal controls in gene expression studies, could have different gene expression
patterns. Group A comprised percutaneous liver biopsies in 14 patients with mildly elevated
alanine aminotransferase in whom all causes of liver disease had been ruled out. Group B
comprised 14 surgical liver biopsies of nontumoral livers. All 28 specimens were histologically
normal. Real-time quantitative reverse-transcription polymerase chain reaction were used to
comparethemessengerRNAexpressionof240selectedgenesinthesetwogroups.Expressionof
26 of the 240 genes was signiﬁcantly different between groups A and B; 23 genes were up-
regulated in group A, while three were down-regulated in group B. The most notable changes
occurredintheinﬂammatoryresponsefamilygenes.Eightgenesdiscriminatedperfectlybetween
groupsAandB:sevenup-regulatedgenes(PAI1,THBS1,IL8,PTGS2,CXCR4,JUN,andFOS),
and one down-regulated gene (IHH). In chronic hepatitis C liver samples, a lower or higher
expression of a IL8 was found depending on whether the controls were obtained percutaneously
orsurgically.Conclusion:Ourstudydemonstratesthathistologicallynormallivertissueobtained
in two different ways (percutaneous or surgical) has different gene expression patterns empha-
sizing the importance of an adequate selection of histologically normal controls to prevent
discordant results in gene expression studies. (HEPATOLOGY 2008;48:953-962.)
G
ene expression proﬁling technologies are used to
analyze gene networks whose expression is asso-
ciated with speciﬁc pathological conditions
compared with normal tissue.1 For instance, in 1999, the
high expression of a speciﬁc group of genes was identiﬁed
in highly proliferative breast tumor cells that were com-
pared with normal breast tissue samples.2
The development of effective tools for large-scale gene
expression analysis has already provided new insights into
the involvement of gene networks and regulatory path-
ways in various tumoral processes.3 Complementary
DNA microarrays can be used to test the expression of
thousands of genes at once, while real-time reverse-tran-
scription polymerase chain reaction (RT-PCR) offers
more accurate and quantitative information on smaller
numbers of selected candidate genes.4-6
We hypothesized that the histologically normal tissue
usually used as normal controls in gene expression studies
obtained in two different ways (that is, percutaneous or
surgical liver biopsies), might have different gene expres-
sion patterns. We suspected that an acute gene response
might be observed during surgery because of aggression
and stress, despite the absence of any macroscopic injury.
To conﬁrm this hypothesis, real-time quantitative RT-
PCR was used to quantify the messenger RNA (mRNA)
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RT-PCR, reverse-transcription polymerase chain reaction.
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953expressionofalargenumberofselectedgenesinpooledA
(histologically normal tissue obtained percutaneously)
specimens compared with pooled B (histologically nor-
mal tissue obtained surgically) specimens. The expression
levelof240genesknowntobeinvolvedinvariouscellular
and molecular mechanisms associated with response to
stress was examined. We especially focused on the expres-
sion of genes related to early stress response, hypoxia, and
inﬂammation.7-12
Genes of interest were further investigated in 14 indi-
vidual group A specimens compared with 14 individual
group B specimens. We then investigated whether the
choice of histologically normal controls could lead to dis-
cordance or misinterpretation of speciﬁc pathological
conditions such as chronic hepatitis C.
Materials and Methods
We selected liver samples on the basis of a histologi-
cally normal pattern: no portal or lobular inﬂammation
and/or necrosis; absence of portal, central, or perisinusoi-
dal ﬁbrosis; and no other signiﬁcant abnormal features
(steatosis 5%, no iron overload, no ballooning or liver
cell clariﬁcation, no cholestasis or bile duct lesion).
Group A
Group A comprised percutaneous normal liver biopsy
specimens, obtained from 14 adults with mildly elevated
serum alanine aminotransferase activity addressed to
Beaujon Hospital (Clichy, France), in whom all causes of
liver disease had been ruled out (medication, alcohol,
chronic viral hepatitis, autoimmune processes, and meta-
bolic disease). In these adults, liver biopsies were per-
formed percutaneously under local anesthesia. A
transparietal biopsy of a normal liver is illustrated in Fig.
1A.
Group B
Surgical liver biopsies of nontumoral livers were ob-
tained from 14 adults during operations for liver metas-
tasis of colorectal cancer (n  7) or benign liver tumors
(n  7) under systemic/general anesthesia. For the pur-
pose of this study, we sampled tissue fragments at least 3
cmfromthenearestmetastasis.Neitherfragmentshowed
portal distorsion or expansion, ductular proliferation, or
cholestasis that could suggest a mass effect. A surgical
biopsy of a normal liver is illustrated in Figure 1B.
All28livertissuespecimensfromgroupAandgroupB
were histologically normal (absence of inﬂammation, ﬁ-
brosis, and pathological pattern).
For all cases, one fragment was frozen and used for
mRNA extraction and another was formalin-ﬁxed and
parafﬁn-embedded. All these samples were carefully re-
viewed by two liver pathologists and considered normal.
Chronic Hepatitis C Patients
Percutaneous liver biopsy specimens obtained from 55
chronic hepatitis C patients, selected from a cohort of
untreated patients with chronic hepatitis C followed at
Beaujon Hospital (Clichy, France), were graded and
staged (Metavir),13 and the gene expression was studied
(A1F1 [n  11], A2F1 [n  9], A1F2 [n  10], A2F2
[n  10], A2F3 [n  15]).
The study was approved by the local ethics committee
and conformed to the 1975 Declaration of Helsinki. All
patients gave informed consent prior to liver biopsy.
Fig. 1. (A) Transparietal biopsy of normal liver. The normal portal tract
and central vein are shown. Hepatocytes are arranged in regular trabec-
ulae (hematoxylin-eosin staining; magniﬁcation 25). (B) Surgical sam-
ple of normal liver. The lobular architecture is well-preserved; the normal
portal tract is present in the center (hematoxylin-eosin staining; magni-
ﬁcation 25).
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Theoretical Basis. Reactions are characterized by the
point during cycling when ampliﬁcation of the PCR
product is ﬁrst detected, rather than the amount of PCR
product accumulated after a ﬁxed number of cycles. The
larger the starting quantity of the target molecule, the
earlier a signiﬁcant increase in ﬂuorescence is observed.
The parameter Ct (threshold cycle) is deﬁned as the frac-
tional cycle number at which the ﬂuorescence generated
bySYBRgreendye–ampliconcomplexformationpassesa
ﬁxedthresholdabovebaseline.Theincreaseinﬂuorescent
signal associated with exponential growth of PCR prod-
ucts is detected by the laser detector of the ABI-Prism
7900 Sequence Detection System (PerkinElmer Applied
Biosystems, Foster City, CA), using PE Biosystems anal-
ysis software according to the manufacturer’s instruc-
tions.
The precise amount of total RNA added to each reac-
tionmix(basedonopticaldensity)anditsquality(thatis,
lack of extensive degradation) are both difﬁcult to assess.
We therefore also quantiﬁed transcripts of two endoge-
nous RNA control genes involved in two cellular meta-
bolicpathways,namelyTBP(Genbankaccessionnumber
NM_003194), which encodes the TATA box-binding
protein (a component of the DNA-binding protein com-
plex TFIID), and RPLP0 (also known as 36B4 [Genbank
accession number NM_001002]), which encodes human
acidic ribosomal phosphoprotein P0. Each sample was
normalized on the basis of its TBP (or RPLPO) content.
Results, expressed as N-fold differences in target gene
expression relative to the TBP (or RPLPO) gene, and
termed Ntarget, were determined as Ntarget  2Ctsample,
where the Ct value of the sample was determined by
subtracting the average Ct value of the target gene from
the average Ct value of the TBP (or RPLP0) gene.
The Ntarget values of the samples were subsequently
normalized such that the median value of the percutane-
ous normal liver specimen Ntarget was 1.
Primers and Controls. We suspected that, during
surgery, as during aggression or stress, an acute gene re-
sponse would be observed despite the absence of macro-
scopicinjury.Basedonastudyoftheliteraturedescribing
early gene expression changes during aggression (associ-
ated with stress), we selected 240 genes involved in vari-
ous cellular and molecular mechanisms associated with
response to stress and during hepatic stellate cell activa-
tion, because these cells participate in the remodeling of
injuredlivers.7-12Thesegenesencodeproteinsinvolvedin
the immune response, extracellular remodeling, oxidative
stress, signal transduction pathways, cell cycle control,
apoptosis, angiogenesis, interferon signaling, and so
forth. Approximately 10 to 20 genes were selected per
pathway (Fig. 2).
Primers for TBP, RPLP0, and the 240 target genes
werechosenwiththeassistanceoftheOligo5.0computer
program (National Biosciences, Plymouth, MN).
We conducted searches in the dbEST and nr databases
to conﬁrm the total gene speciﬁcity of the nucleotide se-
quences chosen as primers and the absence of single nu-
cleotide polymorphisms. In particular, the primer pairs
were selected to be unique relative to the sequences of
closelyrelatedfamilymembergenesorofthecorrespond-
ingretro-pseudogenes.Toavoidampliﬁcationofcontam-
inatinggenomicDNA,oneofthetwoprimerswasplaced
at the junction between two exons, if possible. In general,
amplicons were between 70 and 120 nucleotides long.
Gel electrophoresis was used to verify the speciﬁcity of
PCR amplicons.
For each primer pair, we performed no-template con-
trol and no-RT control (RT-negative) assays, which pro-
duced negligible signals (usually 40 in Ct value),
suggesting that primer–dimer formation and genomic
DNA contamination effects were negligible.
RNA Extraction. Total RNA was extracted from fro-
zen liver tissue samples using the acid-phenol guani-
dinium method. The quality of the RNA samples was
determined via electrophoresis through agarose gels and
staining with ethidium bromide, the 18S and 28S RNA
bands being visualized under ultraviolet light.
Complementary DNA Synthesis. Total RNA was re-
verse-transcribed in a ﬁnal volume of 20 L containing
1 RT buffer (500 M each deoxyribonucleotide
triphosphate, 3 mM MgCl2, 75 mM KCl, 50 mM Tris-
HCl[pH8.3]),20URNasinribonucleaseinhibitor(Pro-
mega, Madison, WI), 10 mM dithiothreitol, 100 U
Superscript II ribonuclease H reverse transcriptase (In-
vitrogen,CergyPontoise,France),3Mrandomhexam-
ers (Pharmacia, Uppsala, Sweden), and 100 ng total
RNA. The samples were incubated at 20°C for 10 min-
utes and 42°C for 30 minutes, and reverse-transcription
was inactivated by heating at 99°C for 5 minutes and
cooling at 5°C for 5 minutes.
PCR Ampliﬁcation. All PCR reactions were per-
formed using an ABI-Prism 7900 Sequence Detection
System (PerkinElmer Applied Biosystems) and the SYBR
GreenPCRCoreReagentskit(PerkinElmerAppliedBio-
systems). Ten microliters of diluted sample complemen-
tary DNA (produced from 2 ng of total RNA) was added
to 15 L of the PCR master mix. The thermal cycling
conditionscomprisedaninitialdenaturationstepat95°C
for 10 minutes, and 50 cycles at 95°C for 15 seconds and
65°C for 1 minute.
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First,twopoolsofﬁveliverspecimensfromeachgroup
were respectively constituted by mixing aliquots of equiv-
alentamountsofRNAfromeachoftheliversamples.We
then determined the mRNA expression level of the 240
genes in each pool. Genes whose expression differed be-
tween pools by at least three-fold in group B versus group
Awereselected.Thisrobustselectioncriterionensuresthe
identiﬁcation of genes of marked interest.
The expression level of these selected genes was then
assessedineachofthe28individualsamples.Comparison
ofthepoolvalueswiththemeanindividualvaluesshowed
that RNA pooling was an appropriate initial screening
approach, signiﬁcantly limiting the required number of
PCRexperiments.Usingthesameapproach,wehavepre-
viously shown the involvement of several altered molecu-
lar pathways in the genesis of hepatitis C virus (HCV)
infection,4 breast cancer,14 and hepatitis C liver ﬁbrosis.5
Statistical Analysis
Relationships between the molecular markers and his-
tologicalparameters(inbothgroupAandgroupBandin
chronic hepatitis C) were tested using the nonparametric
Mann-Whitney U test.15 Differences between the two
populations were judged signiﬁcant at conﬁdence levels
above95%(P0.05).Tovisualizethecapacityofagiven
molecular marker to discriminate between two popula-
tions (in the absence of an arbitrary cutoff value), we
summarized the data in a receiver operating characteristic
(ROC) curve.16
The mRNA levels indicated in Tables 1 and 2 (calcu-
lated as described in Materials and Methods) show the
abundance of the target relative to the endogenous con-
trol (TBP) to normalize the starting amount and quality
of total RNA. Similar results were obtained with a second
endogenous control, RPLP0 (also known as 36B4) (data
not shown).
Results
mRNA Expression of the 240 Genes in the Group B
Pool Sample Relative to the Group A Pool Sample.
The mean TBP gene Ct (threshold cycle) values for the
Fig. 2. List of the 240 genes studied.
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and 25.43  0.23, respectively.
Seven (2.9%) of the 240 genes were detectable but not
reliably quantiﬁable in both the group B and group A pools
(Ct  32). The mRNA expression of 32 (13.7%) of the
remaining 233 genes showed at least a three-fold difference
between the two pools; 27 (84.4%) genes were up-regulated
and 5 (15.6%) were down-regulated in the group B pool
sample compared with the goup A pool sample.
mRNA Expression of the 32 Dysregulated Genes in
14 Group B Samples and 14 Group A Samples. The
expressionlevelofthe32dysregulatedgenesidentiﬁedvia
pooled sample analysis was then determined individually
in the 14 group B samples and 14 group A samples.
Twenty-three (85.2%) of the 27 up-regulated genes
identiﬁedbypooledsampleanalysisweresigniﬁcantlyup-
regulated in the 14 group B samples compared with the
14 group A samples (P  0.05; Table 1). Three (60%) of
the ﬁve down-regulated genes identiﬁed via pooled sam-
ple analysis were signiﬁcantly down-regulated in the 14
group B samples compared with the 14 group A samples
(P  0.05; Table 1).
The 23 up-regulated genes mainly encoded proteins
involved in immune response (interferon pathway,
growth factor, growth factor receptor, cytokine: IL8,
CXCR4,CCL2,CXCL1,IL6,CCL3,CCL4,LIF,CXCL5,
IL1A);andmatrixremodeling(angiogenesis,extracellular
matrix, extracellular matrix protease, inhibitors of matrix
Table 1. Signiﬁcantly Dysregulated Genes in Surgical Nontumoral Liver Patients Relative to Percutaneous Normal Liver
Patients
Gene
Symbols
Alternate
Symbols Gene Name
Gene
Characterization
Percutaneous
Normal Liver
(n  14)
Surgical
Nontumoral
Liver
(n  14) P Value*
ROC-
AUC
Signiﬁcantly up-regulated genes in surgical nontumoral liver patients
PAI1 SERPINE1 Plasminogen activator inhibitor-1 Extracellular matrix 1.0 (0.2-3.6)† 29.7 (9.5-83.9) 0.0000067 1.000
THBS1 TPS1 Thrombospondin-1 Extracellular matrix 1.0 (0.3-1.9) 12.4 (5.6-81.2) 0.0000067 1.000
IL8 Interleukin-8 Growth factor/cytokine 1.0 (0.6-2.1) 97.9 (3.8-434.7) 0.0000067 1.000
PTGS2 COX2 Prostaglandin-endoperoxide synthetase-2 Angiogenesis 1.0 (0.4-1.4) 11.1 (2.5-40.7) 0.0000067 1.000
CXCR4 Chemokine (C-X-C motif) receptor-4 Growth factor receptor 1.0 (0.3-1.6) 5.9 (2.1-19.4) 0.0000067 1.000
JUN Jun oncogene Transcription factor 1.0 (0.2-1.9) 14.0 (3.7-22.5) 0.0000067 1.000
FOS Fos oncogene Transcription factor 1.0 (0.3-14.8) 57.9 (23.3-220.9) 0.0000067 1.000
CCL2 MCP-1 Chemokine (C-C motif) ligand-2 Growth factor/cytokine 1.0 (0.5-2.3) 13.6 (1.2-40.1) 0.000014 0.982
SOCS3 SSI-3 Suppressor of cytokine signaling-
3 (SSI-3)
Signal transduction 1.0 (0.2-2.4) 28.5 (1.2-71.9) 0.000035 0.959
CXCL1 GRO1 Chemokine (C-X-C motif) ligand-1 Growth factor/cytokine 1.0 (0.4-2.2) 9.2 (0,9-56.0) 0.000043 0.954
HIF1A Hypoxia-inducible factor-1, alpha Angiogenesis 1.0 (0.4-1.5) 2.5 (1.1-6.1) 0.000053 0.949
MMP9 Matrix metalloproteinase-9 Extracellular matrix 1.0 (0.3-6.0) 15.0 (0.8-74.2) 0.000094 0.934
CTGF Connective tissue growth factor Growth factor/cytokine 1.0 (0.1-4.6) 5.4 (0.7-16.8) 0.00020 0.913
HAS2 Hyaluronan synthase-2 Extracellular matrix 1.0 (0.5-2.1) 11.0 (0.1-41.8) 0.00024 0.908
IL6 Interleukin-6 Growth factor/cytokine 1.0 (0.3-7.9) 58.9 (0.2-338.9) 0.00048 0.888
EGR1 KROX-24 Early growth response-1 (KROX-24) Transcription factor 1.0 (0.2-16.4) 7.1 (2.9-18.9) 0.00048 0.888
CCL3 MIP-1A Chemokine (C-C motif) ligand-3 (MIP-1A) Growth factor/cytokine 1.0 (0.5-4.0) 6.7 (0.5-21.5) 0.00048 0.888
CCL4 MIP-1B Chemokine (C-C motif) ligand-4 (MIP-1B) Growth factor/cytokine 1.0 (0.3-2.4) 2.9 (0.3-10.3) 0.0028 0.832
PAI2 SERPINB2 Plasminogen activator inhibitor-2 Extracellular matrix 1.0 (0.0-11.4) 26.7 (0.0-165.2) 0.0035 0.824
CDKN1A P21 Cyclin-dependent kinase inhibitor
1A (p21 protein)
Cell cycle regulation 1.0 (0.2-3.4) 2.7 (0.5-9.3) 0.0041 0.819
LIF Leukemia inhibitory factor Growth factor/cytokine 1.0 (0.3-4.2) 5.1 (0.3-17.5) 0.0051 0.811
CRP C-reactive protein Hepatic secretory protein 1.0 (0.3-14.1) 14.9 (0.4-132.8) 0.0067 0.801
MMP2 Matrix metalloproteinase-2 Extracellular matrix 1.0 (0.4-3.0) 1.9 (0.6-24.0) 0.039 0.730
CXCL5 ENA78 Chemokine (C-X-C motif) ligand-5 Growth factor/cytokine 1.0 (0.1-18.6) 3.5 (0.3-143,8) NS 0.702
COL1A2 Collagen, type I, alpha-2 Extracellular matrix 1.0 (0.5-2.9) 1.1 (0.1-42.5) NS 0.594
IL1A Interleukin 1, alpha Growth factor/cytokine 1.0 (0.0-4.4) 0.9 (0.0-13.0) NS 0.582
COL1A1 Collagen, type I, alpha-1 Extracellular matrix 1.0 (0.0-2.6) 0.8 (0.4-86.4) NS 0.467
Signiﬁcantly down-regulated genes in surgical nontumoral liver patients
IHH Indian hedgehog homolog Growth factor/cytokine 1.0 (0.28-2.01) 0.06 (0.01-0.20) 0.0000067 0.000
GPT Alanine aminotransferase Metabolic enzyme 1.0 (0.31-2.78) 0.38 (0.07-1.29) 0.00048 0.112
IREG1 SLC11A3, HFE4 Ferroportin-1 Iron metabolism 1.0 (0.55-1.72) 0.54 (0.21-1.66) 0.003 0.171
CYP2E1 Cytochrome P450 CYP2E1 Metabolic enzyme 1.0 (0.49-2.47) 0.69 (0.30-1.48) NS 0.283
GFAP Glial ﬁbrillary acidic protein Cytoskeletal 1.0 (0.34-8.94) 0.45 (0.22-14.94) NS 0.298
Abbreviations: AUC, area under the curve analysis; NS, not signiﬁcant; ROC, receiver operating characteristics.
*Mann-Whitney U test.
†Median (range) of gene mRNA levels.
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HAS2, PAI2, MMP2, and COL1A1).
Thecapacityofeachofthese26dysregulatedgenes(23
up-regulated and 3 down-regulated) to discriminate be-
tween group B and group A samples was then tested via
ROC curve analysis. The overall diagnostic values of the
26 molecular markers were assessed in terms of their area
under the curve (AUC) values (Table 1).
Eight genes perfectly discriminated between groups A
and B (AUC-ROC, 1.000): seven up-regulated genes
(PAI1, THBS1, IL8, PTGS2, CXCR4, JUN, and FOS)
and one down-regulated gene (IHH). Fig. 3 shows the
mRNA levels of three of these genes (PAI1, THBS1, and
IHH)ineachofthe14groupBsamplesandthe14group
A samples.
Among the eight genes that discriminated perfectly
between the group B and group A samples, there was no
signiﬁcant difference in samples from group B when they
were compared for the nature (that is, benign or malig-
nant) of the distant tumor (Table 2).
mRNA Expression of IL8 in Different Stage of
Chronic Hepatitis C in Comparison with Group B
Samples and Group A Samples. To determine whether
the choice of histologically normal controls could lead to
discordance or misinterpretation of speciﬁc pathological
conditions such as chronic hepatitis C, we measured one
(IL8) of the eight perfectly discriminating genes in ﬁve
series of various grades of necroinﬂammation and stages
of liver ﬁbrosis (A1F1, A2F1, A1F2, A2F2, A2F3).
IL8 was investigated because it has been shown in cul-
ture cells that the HCV nonstructural 5A protein induces
IL8.17IL8mRNAexpressionincreasesfrommildchronic
hepatitis C (A1F1) to severe liver lesions (A2F3) (Fig. 4).
The results show an underexpression or overexpression of
speciﬁc genes (such as IL8) in HCV infection depending
on whether the controls were obtained percutaneously or
surgically. It is interesting to note that in this example,
group A seems to be the more appropriate control, be-
cause an increase in IL8 mRNA levels from mild (A1F1)
to advanced disease (A2F3) is observed, suggesting a
model with IL8 activation during ﬁbrogenesis.
mRNA Expression of Other Genes Involved in the
Hedgehog-Gli Signaling Pathway in Group B and
Group A Samples. The only down-regulated gene that
perfectly discriminated between groups A and B (IHH)i s
involved in the Hedgehog-Gli signaling pathway. To fur-
ther explore the Hedgehog-Gli signaling pathway to dis-
criminate between groups A and B, we tested the
expressionofsixadditionalgenesinvolvedinthispathway
(DHH, SHH, GLI1, GLI2, GLI3, and GLI4) in three
Table 2. Genes Perfectly Discriminated Between Percutaneous Normal Liver and Surgical Nontumoral Liver Patients
According to Nature of the Adjacent Tumor (Benign Versus Malignant) in the Surgical Nontumoral Group
Gene
Symbols
Alternate
Symbols
Gene
Name
Gene
Characterization
Percutaneous
Normal Liver
(n  14)
Surgical
Nontumoral Liver
(n  14)
Surgical Nontumoral
Liver Patients
Adjacent to Benign
(n  7)
Surgical Nontumoral
Liver Patients
Adjacent to
Malignant
(n  7)
P
Value*
ROC-
AUC
Genes up-regulated in surgical nontumoral liver patients
PAI1 SERPINE1 Plasminogen
activator
inhibitor-1
Extracellular
matrix
1.0 (0.2-3.6)† 29.7 (9.5-83.9) 19.0 (9.5-83.9) 31.1 (9.6-46.5) NS 0.633
THBS1 TPS1 Thrombospondin-1 Extracellular
matrix
1.0 (0.3-1.9) 12.4 (5.6-81.2) 7.6 (5.6-81.2) 19.9 (9.4-25.7) NS 0.816
IL8 Interleukin-8 Growth factor/
cytokine
1.0 (0.6-2.1) 97.9 (3.8-434.7) 80.1 (11.7-434.7) 115.7 (3.8-381.1) NS 0.388
PTGS2 COX2 Prostaglandin-
endoperoxide
synthetase-2
Angiogenesis 1.0 (0.4-1.4) 11.1 (2.5-40.7) 12.9 (5.5-34.4) 9.3 (2.5-40.7) NS 0.816
CXCR4 Chemokine (C-X-C
motif) receptor-
4
Growth factor
receptor
1.0 (0.3-1.6) 5.9 (2.1-19.4) 6.0 (2.1-12.4) 4.2 (2.4-19.4) NS 0.490
JUN Jun oncogene Transcription
factor
1.0 (0.2-1.9) 14.0 (3.7-22.5) 13.1 (6.2-21.5) 14.9 (3.7-22.5) NS 0.510
FOS Fos oncogene Transcription
factor
1.0 (0.3-14.8) 57.9 (23.3-220.9) 69.0 (23.3-220.9) 38.6 (29.6-111.3) NS 0.388
Genes down-regulated in surgical nontumoral liver patients
IHH Indian Hedgehog
homolog
Growth factor/
cytokine
1.0 (0.28-2.01) 0.06 (0.01-0.20) 0.07 (0.02-0.20) 0.06 (0.01-0.16) NS 0.378
Abbreviations: AUC, area under the curve analysis; NS, not signiﬁcant; ROC, receiver operating characteristics.
*Mann -Whitney U test (venign versus malignant).
†Median (range) of gene mRNA levels.
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and three low IHH-overexpressing surgical nontumoral
liver samples. The results are summarized in Fig. 5.DHH
transcriptsweredetectablebutnotreliablyquantiﬁablein
both the group B and group A samples (Ct  32). Total
positive associations (AUC-ROC, 1.000) were found be-
tween IHH and three of the ﬁve expressed genes (SHH,
GLI1, and GLI4).
Discussion
Gene expression proﬁling technologies are used to an-
alyze gene networks whose expression is associated with
speciﬁc pathological conditions compared with normal
tissue.1 Generally, normal tissue for normal controls is
obtained in various ways, including percutaneous and
surgical biopsy.1-2,5,18
This study focused on the gene expression changes ob-
served in the histologically normal liver in relation to the
sampling method (percutaneous or surgical liver biopsy).
We analyzed the gene transcriptional proﬁles of percuta-
neous normal liver specimens, obtained under local anes-
thesia from 14 adults with mildly elevated serum alanine
aminotransferase activity in whom all causes of liver dis-
ease had been ruled out (medication, alcohol, chronic
viral hepatitis, autoimmune processes, and metabolic dis-
ease) compared with nontumoral liver biopsies obtained
from 14 adults during surgery for liver metastasis of colo-
Fig. 3. Shown are the mRNA levels of three perfectly discriminatory
genes (PAI1, THBS1, IHH) in the 14 percutaneous normal liver samples
and the 14 surgical nontumoral liver samples. The median value (range)
is indicated for each subgroup. NL, normal liver.
Fig. 4. IL8 expression in different grade of necroinﬂammation and
stage of ﬁbrosis in chronic hepatitis C as compared with group B or
group A.
Fig. 5. Expression level of Hedgehog/Gli genes in three high IHH-
expressing percutaneous normal liver samples and three low IHH-ex-
pressing surgical nontumoral liver samples. NL, normal liver.
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specimens (groups A and B) were histologically normal.
For our study, we selected liver samples based on a histo-
logical normal aspect carefully analyzed by two liver pa-
thologists.
The 26 genes that were signiﬁcantly dysregulated (23
up-regulated and three down-regulated) in the group B
samples mainly encoded proteins involved in immune
response (interferon pathway, growth factor, growth fac-
tor receptor, cytokine: IL8, CXCR4, CCL2, CXCL1, IL6,
CCL3, CCL4, LIF) and matrix remodeling (angiogenesis,
extracellular matrix, extracellular matrix protease, inhibi-
tors of matrix protease: PAI1, THBS1, PTGS2, HIF1A,
MMP9, CTGF, HAS2, PAI2, and MMP2). The gene up-
regulations in the surgical nontumoral biopsies were not
duetotumorcellcontaminationorstromacellactivation,
becausesimilarexpressionlevelswereobservedinthenor-
mal liver samples associated with distant malignant tu-
mors compared with those associated with distant benign
tumors.
Most of these genes belong to the acute phase response
family and are up-regulated after “stress.”19 All living or-
ganisms need to sense and respond to conditions that
stress their homeostatic mechanisms. The liver plays a
central role in the body’s response to injury.20 Expression
of hepatic acute-phase and heat-shock genes probably
contributes to restoring homeostasis after surgical proce-
dures. Activation of the acute phase response can be due
to different causes, such as hypoxemia, infection, surgery,
and anesthesia. The acute phase response gene family in-
cludes and/or interacts with numerous family genes (in-
ﬂammation,cytokines,extracellularmatrix,andsoforth).
Systemicstressorscanleadtoregeneration.12Hypoxia—a
reduction in the normal level of tissue oxygen tension—
occursduringacuteandchronicvasculardiseases,pulmo-
narydiseaseandcancer.21Anothertypeofhypoxiaknown
as acute or perfusion-limited hypoxia occurs when aber-
rant blood vessels are shut down, which also causes a
reverse in blood ﬂow. Closed vessels can be reopened,
leading to reperfusion of hypoxic tissue with oxygenated
blood. This leads to an increase in free radical concentra-
tions, tissue damage, and activation of stress-response
genes—a process known as reoxygenation injury. It
shouldbenotedthatdysregulationofHIF1A,ageneplay-
ing a major role in hypoxia, was observed in this study.
What about surgical liver biopsies under general anes-
thesia? General anesthetics are known to transiently in-
crease expression of mRNAs of immediate-early genes in
the brain.22 Furthermore, anesthesia has been shown to
mimic ischemic preconditioning,23 the process by which
brief exposure to ischemia provides robust protection or
tolerance against the injurious effects of longer-term isch-
emia via expression of acute phase response genes.
Among the 26 dysregulated genes identiﬁed in this
study, eight perfectly discriminated between groups A
and B (AUC-ROC, 1.000): seven up-regulated genes
(PAI1, THBS1, PTGS2, CXCR4, JUN, FOS, and IL8) all
involved in the acute phase response, and one down-reg-
ulatedgene(IHH)thatcodesoneofthethreemammalian
Hedgehog (Hh) proteins playing a major role in verte-
brate development and tumorigenesis.
THBS1, PAI1. THBS1 and PAI1 code molecules in-
volved in matrix turnover. Thrombospondins form a
family of secreted glycoproteins with pleiotropic func-
tions and widespread expression.24-26 THBS1 is involved
intheregulationofcellularresponsestoinjury.Ithasbeen
shown that THBS1 acts as a strong promoter of trans-
forming growth factor  effects in hepatic stellate cells.27
Plasminogen activator inhibitor-1 (PAI-1) is the main
physiological inhibitor of both the urokinase-type plas-
minogen activator and the tissue plasminogen activator
and thereby plays an important role in regulation of the
ﬁbrinolytic system. PAI-1 has also been reported to act as
an acute phase protein,28 and plasma PAI-1 levels rise
markedly during disease states often associated with an
acute phase response, including trauma, surgical proce-
dures, and burn injury. The inﬂammatory response is a
nonspeciﬁcreactionofthehumanbodytotrauma,injury,
or infection, and the liver is a major site for synthesis of
inﬂammatory and procoagulant mediators, including C-
reactive protein, ﬁbrinogen, interleukin-6, and PAI-1.29
CXCR4,IL8,andPTGS2. CXCR4,IL8,andPTGS2
code molecules involved in angiogenesis and inﬂamma-
tion.
Stromal cell–derived factor-1 is a member of the C-
X-C motif (CXC) chemokine family that binds to the
seven-span transmembrane G-protein–coupled CXCR4
receptor, which has stromal cell–derived factor-1 as its
unique ligand.30 CXCR4 is expressed by most leukocyte
populations, endothelial cells, as well as epithelial and
carcinomatous cells. In a recent study, hepatic regenera-
tion was induced by treating rats with 2-acetylaminoﬂu-
orene and followed by partial hepatectomy.31 CXCR4
mRNA expression, assessed by both quantitative RT-
PCR and in situ hybridization, was increased during he-
patic regeneration.
PTGS2, also called COX-2, plays an important role in
tumor and endothelial cell biology. Increased expression
of PTGS2 occurs in multiple cells within the tumor mi-
croenvironment, which can affect angiogenesis. PTGS2
appears to play a key role in the release and activity of
proangiogenic proteins.32
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ily, plays an important role in tumor progression and
metastasis in a variety of human cancers, including lung
cancers.33 Interleukin-8 biological activity in tumors and
the tumor microenvironment may contribute to tumor
progression through its potential function in the regula-
tion of angiogenesis, cancer cell growth and survival, tu-
mor cell motion, leukocyte inﬁltration, and modiﬁcation
of immune responses.
IL8 mRNA expression increases from mild chronic
hepatitis C (A1F1) to severe liver lesions (A2F3). In prior
immunohistochemical studies of HCV infection, IL8
protein was shown to be expressed in inﬁltrating cells in
the portal tract and ﬁbrotic septa and within hepatic lob-
ules in patients.34 We have previously reported that there
was a correlation between intrahepatic mRNA IL8 ex-
pression and hepatic ﬁbrosis in HCV patients.5 More-
over, exposure of human umbilical vein endothelial cells
to HCV-like particles resulted in increased IL8 produc-
tion.35
JUN, FOS. The AP-1 transcription factor is mainly
composed of Jun, Fos, and/or ATF protein heterodimers.
AP-1mediatesgeneregulationinresponsetoaplethoraof
physiological and pathological stimuli, including cyto-
kines,growthfactors,stresssignals,andbacterialandviral
infections, as well as oncogenic stimuli.36 Interestingly, a
ratmodelafterportalbranchligationproducedatrophyof
the deprived lobes (70% of the liver parenchyma),
whereas the perfused lobes undergo compensatory regen-
eration; c-fos and c-jun expression were elevated during
theﬁrst2hoursinallthecompartments.37Theseﬁndings
suggest that the cellular and molecular changes that occur
early in a regenerating liver are nonspeciﬁc, possibly
stress-induced cellular responses. They do not indicate
future progression toward atrophy or regeneration.
IHH and the Mammalian Hedgehog Proteins.
Amongthe26dysregulatedgenes,weidentiﬁedeightthat
perfectly discriminated between group A and group B
(AUC-ROC, 1.000), one of which is a down-regulated
gene (IHH) that codes one of the three mammalian
Hedgehog (Hh) proteins. Alteration of this unexpected
pathway was conﬁrmed via identiﬁcation of an alteration
of additional genes involved in this signaling pathway
(oneadditionalligand[SHH]andtwotranscriptionalfac-
tors [GLI1] and [GLI4]). The Hh pathway has been
shown to direct the fate of neural and myoﬁbroblastic
cells during embryogenesis and during tissue remodeling
in adults.38-39 Recent studies suggest a major role for the
Hh pathway in hepatic stellate cell activation and viabili-
ty40andinthemaintenanceofhepaticprogenitorsduring
fetal development and adulthood.41 Fatty liver injury al-
ters Hh activity in liver progenitors, and this might pro-
mote epithelial–mesenchymal transitions that result in
liver ﬁbrosis.42 Hh dysregulation is also observed in hu-
man hepatocarcinogenesis.43 Our results regarding Hh
signaling could suggest qualitative or quantitative varia-
tions in hepatic stellate cells and/or hepatic progenitors
between percutaneous and surgical normal liver tissues.
This study demonstrates that histologically normal
liver tissue obtained in two different ways (percutaneous
or surgical liver biopsy) has different gene expression pat-
terns,thoughallspecimensarehistologicallynormal.The
most notable changes in gene expression mainly occurred
intheinﬂammatoryresponsegenefamily.Therefore,this
studyemphasizestheimportanceofanadequateselection
of histologically normal controls to prevent discordant or
false results in gene expression proﬁle analysis.
It is difﬁcult to state which is the best histologically
normal control. In any study, the appropriate histological
normal control should be obtained in the same technical
wayasthepathologicalsample.Forinstance,inastudyof
chronic hepatitis C in which liver samples are obtained
percutaneously, the histologically normal samples should
be obtained through percutaneous liver biopsy.4-6 In all
cases, the controls used should be clearly described. Fi-
nally, the careful selection of controls is crucial, since the
wrongselectioncouldleadtomisinterpretationofresults.
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